Ying Huang, Legend Biotech CEO
July 26, 2022 07:17 AM EDT
Financing

Leg­end seeks $250M af­ter pos­i­tive #AS­CO22 da­ta, but chal­lenges re­main for the J&J part­ner

Max Gelman

Senior Editor

J&J-part­nered Leg­end Biotech has had its share of both good and bad news in re­cent weeks, and ex­ecs ev­i­dent­ly be­lieve the for­mer out­weighs the lat­ter …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

A service from the Financial Times